Early Lymphopenia and Infections in Nontraumatic Subarachnoid Hemorrhage Patients

J Neurosurg Anesthesiol. 2022 Apr 1;34(2):243-247. doi: 10.1097/ANA.0000000000000744.

Abstract

Introduction: Subarachnoid hemorrhage (SAH) is associated with high morbidity and mortality. A certain degree of immunodepression has been reported during critical illness, and lymphopenia identified as an independent predictor of poor outcome; no data are available for critically ill SAH patients. We aimed to evaluate the prevalence of lymphopenia among SAH patients and its association with hospital-acquired infection.

Methods: Retrospective cohort study of adult patients admitted to an intensive care unit with nontraumatic SAH between January 2011 and May 2016. Lymphocyte count was obtained daily for the first 5 days; lymphopenia was defined as lymphocyte count <1000/mm3. The occurrence of infection during the first 21 days after hospital admission, hospital mortality, and unfavorable neurological outcome (Glasgow Outcome Scale score 1 to 3 at 3 mo) were recorded.

Results: Data from 270 patients were analyzed (median age 54 y; male 45%); 121 (45%) patients had lymphopenia and 62 (23%) patients developed infections. Median (25th to 75th percentiles) lymphocyte count at hospital admission was 1280 (890 to 1977)/mm3. Lymphopenia patients had more episodes of infection (38/121, 31% vs. 24/139, 17%; P=0.003) than nonlymphopenia patients, while mortality and unfavorable outcome were similar. Lymphopenia was not independently associated with the development of infection, unfavorable neurological outcome or with mortality.

Conclusions: Early lymphopenia is common after SAH, but is not significantly associated with the development of infections or with poor outcome.

MeSH terms

  • Adult
  • Critical Illness
  • Humans
  • Intensive Care Units
  • Lymphopenia* / complications
  • Lymphopenia* / etiology
  • Male
  • Middle Aged
  • Retrospective Studies
  • Subarachnoid Hemorrhage* / complications
  • Subarachnoid Hemorrhage* / epidemiology
  • Treatment Outcome